Linical

Basic Information

Stock Code
2183
Industry
Services
Category Detail
Biotechnology & Pharmaceuticals
Prefecture
Osaka Prefecture
Establishment Year
June 2005
Listing Year
October 2008
Official Website
https://www.linical.co.jp/
TSE Information
TSE Information
Yahoo! Finance
Yahoo! Finance
Other Companies
Syncrea, Kojin Bio, Seigakusha, Transgenic Group, Shin Nihon Kagaku, DNA Chip Research Institute, Primecs, H.U. Group Holdings, Falco Holdings, BML, Human Metabolome Technologies, PhoenixBio

Overview

Linical is a CRO company founded in 2005 specializing in clinical development support for pharmaceuticals, with strengths in global expansion and one-stop comprehensive service provision.

Current Situation

Linical recorded sales of approximately 12.5 billion yen, ordinary income of approximately 1.3 billion yen, and net assets of approximately 7.6 billion yen for the fiscal year ended March 2023, maintaining a solid financial foundation. Its main CRO business focuses on clinical trial support domestically and internationally, while also developing drug discovery support and drug nurturing businesses, contributing to international clinical development. Through subsidiaries in Korea, the United States, and Europe, it provides global services and has established a one-stop integrated management system for diverse projects. Compared to competitors in the industry, its pharmaceutical development expertise and broad overseas expansion are evaluated as key sources of competitiveness. It is proactive in technological innovation, with high expectations for AI utilization and digital therapeutics. In terms of sustainability, it promotes ethical compliance in pharmaceutical development and environmental considerations, advancing management aware of social responsibility. Moving forward, it aims for sustained growth by expanding international clinical development projects and entering new areas as strategic goals.

Trivia

Interesting Facts

  • Company established by former development staff of Fujisawa Pharmaceutical.
  • Aiming to be a Japan-originated global CRO since its founding.
  • Expanded global presence by acquiring multiple overseas CRO companies.
  • One of the few companies specialized in one-stop clinical trial services.
  • Supports not only pharmaceuticals but also medical devices and regenerative medicine.
  • Innovative company actively introducing AI and digital technologies.
  • Strong focus on drug nurturing support for pharmaceuticals.
  • Group of approximately 759 specialists.
  • Occupies an important position in Japan's pharmaceutical clinical trial support market.
  • Achieved transition to Tokyo Stock Exchange Standard Market.
  • Characterized by global framework for multinational clinical trials.
  • Has experience in clinical trial site support (SMO) business.
  • Can complete international projects through subsidiaries in Europe, America, and Asia.
  • Renowned for regulatory compliance capabilities in pharmaceutical development.
  • High project management capabilities in the CRO field.

Hidden Connections

  • Powerful collaboration base from talent network split from former Fujisawa Pharmaceutical.
  • Built global partnership network through acquisitions of subsidiaries in Europe, U.S., and Korea.
  • Leverages historical background from Astellas Pharma's establishment as a strength.
  • Maintains good relations with domestic and international clinical trial sites and has SMO business experience.
  • Deep relations with adjacent industries through support for broad product development including regenerative medicine.
  • Clinical trial support services utilizing AI and ICT promote technological collaboration within the pharmaceutical industry.
  • Information sharing network exists with multinational companies in international regulatory compliance for pharmaceutical development.
  • Has partnership examples with industry competitors and develops joint projects.

Future Outlook

Growth Drivers

  • Increasing demand for global clinical trials
  • Advancement of clinical trial efficiency through digitalization
  • Expansion of regenerative medicine-related markets
  • Progress in AI and big data utilization
  • Increasing demand for advanced support due to regulatory strengthening
  • Accelerated expansion into Asian emerging markets
  • Increasing service demand from multinational clinical trials

Strategic Goals

  • Achieve over 70% global sales ratio
  • 40% improvement in clinical trial efficiency through digital solutions
  • Establish annual sales of 2 billion yen scale in regenerative medicine
  • Strengthen sustainability promotion and CSR enrichment
  • Enhance expertise through advanced talent development
  • Maximize customer satisfaction through strengthened collaboration with overseas subsidiaries
  • Complete overhaul of ICT infrastructure and promotion of AI utilization
  • Organizational revitalization through diversity promotion
  • Establish position as industry leading company
  • Strengthen international regulatory compliance and contribute to industry standardization

Business Segments

Clinical Trial Support

Overview
Provides comprehensive support for clinical development of pharmaceuticals and regenerative medicine products, including regulatory authority responses.
Competitiveness
One-stop support for multi-regional clinical trials through global network
Customers
  • Pharmaceutical Companies
  • Biotech Ventures
  • Medical Device Manufacturers
  • Regenerative Medicine Companies
  • Public Research Institutions
  • University Hospitals
  • Medical Consultants
Products
  • Clinical Trial Coordination Services
  • Data Management
  • Monitoring Services
  • Statistical Analysis
  • Safety Information Management
  • Regulatory Support
  • Clinical Trial Implementation Planning Support
  • Quality Management Services

Drug Nurturing and Discovery Support

Overview
Supports early stages of new drug development, contributing to improved efficiency and success rates in drug discovery research.
Competitiveness
One-stop services in collaboration with highly specialized development staff
Customers
  • Pharmaceutical Company R&D Departments
  • Biotechnology Companies
  • University Laboratories
  • Drug Discovery Ventures
  • External Research Consultants
Products
  • Drug Candidate Exploration Support
  • Non-clinical Trial Planning
  • Pharmaceutical Affairs Strategy Consulting
  • Biomarker Development
  • Molecular Modeling Analysis

Regulatory Compliance Consulting

Overview
Provides strategic application support aligned with regulatory environments for pharmaceuticals and medical devices.
Competitiveness
Extensive track record in multi-country regulatory compliance
Customers
  • Pharmaceutical Company Approval Departments
  • Medical Device Manufacturers
  • Pharmaceutical Import/Export Companies
Products
  • Domestic and International Application Support
  • Safety Monitoring Program Development
  • Legal Regulation Research and Response Support

Data Science and ICT Support

Overview
Utilizes digital technology to achieve efficiency and quality improvement in clinical development.
Competitiveness
ICT solutions specialized for the pharmaceutical industry
Customers
  • Pharmaceutical Company IT Departments
  • Clinical Trial Institutions
  • Healthcare-related Companies
Products
  • Clinical Data Analysis
  • Electronic Data Collection System Implementation
  • AI Utilization Consulting
  • Clinical Trial Management System Development

Global Business Development Support

Overview
Supports smooth execution of overseas clinical trials and international collaboration.
Competitiveness
Network with local subsidiaries deployed in each region
Customers
  • Japanese Pharmaceutical Global Promotion Departments
  • Overseas Pharmaceutical Companies
  • International Joint Development Teams
Products
  • Multinational Clinical Trial Coordination
  • Overseas Subsidiary Management Support
  • International Regulatory Compliance

SMO (Clinical Trial Site Support Organization) Business

Overview
Provides operational support at clinical trial sites to facilitate efficient trial execution.
Competitiveness
Services closely integrated with medical institutions
Customers
  • Medical Institutions
  • Clinical Trial Coordinators
  • Pharmaceutical Companies
Products
  • Clinical Trial Patient Recruitment Support
  • Clinical Trial Implementation Support
  • Medical Institution Collaboration

Regenerative Medicine Product Development Support

Overview
Provides development support services specialized in regenerative medicine.
Competitiveness
Advanced expertise and responsiveness from specialized staff
Customers
  • Regenerative Medicine Companies
  • Universities and Research Institutions
  • Pharmaceutical Companies
Products
  • Clinical Development Planning
  • Regulatory Compliance Support
  • Safety Evaluation Support

Clinical Trial Education and Training Services

Overview
Implements educational programs to enhance knowledge of clinical trial personnel.
Competitiveness
Practical training based on extensive operational experience
Customers
  • Pharmaceutical Companies
  • Clinical Trial Coordinators
  • Medical Institution Staff
Products
  • Clinical Trial Basics Training
  • GCP Training
  • Safety Monitoring Training

Project Management Support

Overview
Supports efficient advancement of overall clinical development.
Competitiveness
Reliability from extensive project experience
Customers
  • Pharmaceutical Company Development Departments
  • CRO Collaboration Teams
  • Outsourcers
Products
  • Clinical Trial Management Planning
  • Project Progress Management
  • Risk Management

Pharmaceutical Affairs Application Support

Overview
Supports domestic and international pharmaceutical approval processes.
Competitiveness
Specialized knowledge adaptable to regulations in each country
Customers
  • Pharmaceutical Company Pharmaceutical Affairs Departments
  • Regulatory Authority Application Agents
Products
  • New Drug Approval Applications
  • Medical Device Approval Applications
  • Package Insert Creation Support

Drug Information Management Support

Overview
Provides support for drug information analysis and safety management.
Competitiveness
Accurate information management based on long-term track record
Customers
  • Medical Institutions
  • Pharmaceutical Companies
  • Pharmacies
Products
  • Drug Information Monitoring
  • Adverse Event Reporting Support

R&D Support Solutions

Overview
Promotes technological support and efficiency in early-stage research.
Competitiveness
Deployment of highly knowledgeable technical staff
Customers
  • Pharmaceutical Company R&D Departments
  • Biotech Research Institutions
Products
  • Trial Design Consulting
  • Technology Transfer Support

Competitive Advantage

Strengths

  • High-specialty technology in pharmaceutical clinical development support
  • Strengthened global network domestically and internationally
  • Efficient operations through one-stop service provision
  • Abundant overseas subsidiaries and multinational clinical trial track record
  • Advanced regulatory compliance capabilities
  • Packaged diverse clinical trial-related services
  • Excellent project management capabilities
  • Long-term industry experience and reliability
  • Drug nurturing and discovery support adaptable to multiple fields
  • Progress in adopting digital and ICT technologies
  • High employee expertise and education system
  • Management stability and strong financial foundation
  • Rapid decision-making structure
  • Strong relationship building with long-term customers
  • Focus on regenerative medicine field

Competitive Advantages

  • Rich overseas bases as a Japan-originated global CRO
  • Multi-area対応 possible with one-stop pharmaceutical development support
  • Trust gained from abundant clinical trial project track record
  • International standard compliance for various regulations
  • Deployment of specialized regenerative medicine support services
  • Rapid response via multinational network of subsidiaries
  • Strong partnerships with major domestic and international pharmaceutical companies
  • Active introduction of ICT and digital solutions
  • Continuous support system from early drug discovery
  • Provision of high-quality safety management services
  • Specialist development through rich talent nurturing programs
  • Numerous successful project management track records
  • Customer satisfaction through flexible customized services
  • High compliance in environmental and ethical aspects
  • Business area expansion through active M&A

Threats

  • Intensifying price competition from competing CROs
  • Rapid changes in international regulations and increasing response costs
  • Challenges in securing clinical trial patients
  • Rise of local CROs in emerging markets
  • Risk of delay in adapting to new technologies
  • Political risks and trade friction impacts
  • Management risks of overseas subsidiaries
  • Revenue pressure from prolonged pharmaceutical development periods
  • Competition with rapid advances in big data and AI technologies
  • Strengthened business restrictions due to legal regulations
  • External environmental risks such as infectious disease outbreaks
  • Decline in expertise due to talent outflow

Innovations

2023: Completed subsidiary acquisition of U.S. CRO Accelovance

Overview
Strengthens services in the North American market through acquisition of U.S. subsidiary.
Impact
Contributes to expansion of global deployment and strengthening of revenue base.

2021: Launched digital clinical trial support services

Overview
Introduced electronic data collection and remote monitoring technologies.
Impact
Achieves clinical trial efficiency and cost reduction.

2020: Introduced AI-utilizing data analysis platform

Overview
Built a clinical data analysis support system using AI technology.
Impact
Contributes to improved analysis accuracy and decision-making support.

2022: Strengthened global expansion of Korean subsidiary P-pro.Korea

Overview
Expanded clinical trial support system in Asia.
Impact
Improves responsiveness in the Asian market.

2024: Strengthened clinical development support in regenerative medicine

Overview
Established specialized team and launched advanced support services.
Impact
Contributes to new market development and business diversification.

2023: Introduced AI support for project management

Overview
Introduced AI tools to improve project operation efficiency.
Impact
Aims to improve quality and delivery times.

2021: Digitalization of clinical trial patient recruitment platform

Overview
Developed and implemented a system that significantly improves patient recruitment efficiency.
Impact
Contributes to faster clinical trial execution.

2022: Promoted eco-friendly office initiatives to reduce environmental impact

Overview
Advanced energy-saving and paperless operations in offices.
Impact
Reduces environmental impact and costs.

2020: Launched biomarker development support program

Overview
Started support services to improve drug discovery efficiency.
Impact
Contributes to shortening research and development periods.

2023: Developed multinational clinical trial coordination system

Overview
Developed a system to promote standardization and efficiency in clinical trial execution.
Impact
Supports smooth operation of global clinical trials.

Sustainability

  • Thorough ethical compliance in clinical trials
  • Resource conservation to reduce environmental impact
  • Medical education support as CSR activities
  • Talent development through workplace improvement
  • Strengthened global compliance framework
  • Promotion of collaboration with local medical institutions
  • Strict privacy protection for patient information
  • Paper resource reduction through ICT utilization
  • Promotion of environmentally considerate office operations
  • Continuous participation in social contribution activities
  • Practice of transparent information disclosure
  • Respect for diversity and inclusion